Cargando…
Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study
Tumor necrosis factor inhibitor (TNFi) therapies are often the first biologic therapy used to treat rheumatoid arthritis (RA) patients. However, a substantial fraction of patients do not respond adequately to TNFi therapies. A test with the ability to predict response would inform therapeutic decisi...
Autores principales: | Pappas, Dimitrios A., Brittle, Christine, Mossell, James E., Withers, Johanna B., Lim-Harashima, Jeraldine, Kremer, Joel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703510/ https://www.ncbi.nlm.nih.gov/pubmed/33258003 http://dx.doi.org/10.1007/s00296-020-04746-7 |
Ejemplares similares
-
Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
por: Bergman, Martin J., et al.
Publicado: (2020) -
Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey
por: Pappas, Dimitrios A., et al.
Publicado: (2022) -
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
por: Arnell, Christopher, et al.
Publicado: (2021) -
Relationship between perceived stress, stress coping strategies, and clinical status in patients with rheumatoid arthritis
por: Wróbel, Aldona, et al.
Publicado: (2023) -
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data
por: Pappas, Dimitrios A., et al.
Publicado: (2020)